Avenue Therapeutics Inc. (ATXI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Avenue Therapeutics Inc.

    NASDAQ: ATXI · Real-Time Price · USD
    0.69
    -0.06 (-8.00%)
    At close: Oct 02, 2025, 3:12 PM
    0.69
    0.00%
    After-hours: Oct 02, 2025, 03:12 PM EDT

    Avenue Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -11.7M -10.38M -3.6M -3.73M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 1.24M 906K 649K 442K
    Other Working Capital
    		 n/a 70K 23K -55K
    Other Non-Cash Items
    		 1.25M 310K -5.05M n/a
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 179K -290K 408K -461K
    Operating Cash Flow
    		 -9.03M -9.45M -7.6M -3.75M
    Capital Expenditures
    		 n/a -3M n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a -3M n/a n/a
    Investing Cash Flow
    		 n/a -3M n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a -1.1M n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 8.21M 1K 148K -663K
    Financial Cash Flow
    		 9.84M 7.53M 10.54M 4.38M
    Net Cash Flow
    		 811K -4.92M 2.94M 631K
    Free Cash Flow
    		 -9.03M -12.45M -7.6M -3.75M

    Add to Watchlist